gimli
GLAXO stock analysis context
GLAXOSMITHKLINE PHARMA LT Stock Context for AI Screening
GLAXOSMITHKLINE PHARMA LT is a mid-cap stock in Healthcare. This page summarizes key screening signals for GLAXOSMITHKLINE PHARMA LT, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about GLAXOPrice
₹2,306.90
1M return
-6.44%
3M return
-11.17%
Market cap
₹39,080.27 cr
PE
37.53
ROE
+55.85%
RSI
36.95
Turnover
₹42.74 cr
Why it can matter in screens
- Momentum: GLAXO is trend mixed or unavailable; RSI is 36.95.
- Returns: 1M -6.44%, 3M -11.17%, 6M -7.65%.
- Liquidity: latest turnover is ₹42.74 cr.
- Valuation: PE 37.53, PB 17.24, ROE +55.85%, ROCE +75.23%.
- Growth: 3Y sales CAGR +4.51%, 3Y profit CAGR -18.20%.
Try these prompts
- Analyze GLAXOSMITHKLINE PHARMA LT with valuation, momentum and industry peers
- Compare GLAXO with other Healthcare stocks
- Show mid-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View mid-cap stocks
- Find stocks above 50DMA
- Compare GLAXO with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.